OTCIX
Price
$27.98
Change
+$0.03 (+0.11%)
Updated
Sep 18 closing price
Net Assets
12.34B
RPMGX
Price
$97.30
Change
-$0.03 (-0.03%)
Updated
Sep 18 closing price
Net Assets
20.82B
Interact to see
Advertisement

OTCIX vs RPMGX

OTCIX vs RPMGX Comparison Chart in %
View a ticker or compare two or three
VS
OTCIX vs. RPMGX commentary
Sep 21, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OTCIX is a Hold and RPMGX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RPMGX has more cash in the bank: 20.8B vs. OTCIX (12.3B). OTCIX (0.00) and RPMGX (0.00) have matching dividends . OTCIX was incepted earlier than RPMGX: OTCIX (30 years) vs RPMGX (34 years). OTCIX (0.78) and RPMGX (0.77) have similar cost to investors . OTCIX is a more actively managed with annual turnover of: 54.00 vs. RPMGX (31.50). OTCIX has a lower initial minimum investment than RPMGX: OTCIX (0) vs RPMGX (2500). RPMGX annual gain was more profitable for investors over the last year : -5.63 vs. OTCIX (-19.30). OTCIX return over 5 years is better than : -17.22 vs. RPMGX (-24.20).
OTCIXRPMGXOTCIX / RPMGX
Total Expense Ratio0.770.77100%
Annual Report Gross Expense Ratio0.780.77101%
Fund Existence30 years34 years-
Gain YTD0.1790.062290%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets12.3B20.8B59%
Annual Yield % from dividends0.000.00-
Returns for 1 year-19.30-5.63342%
Returns for 3 years6.67-0.19-3,595%
Returns for 5 years-17.22-24.2071%
Returns for 10 years84.0827.75303%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GGOAX11.150.01
+0.09%
Goldman Sachs Mid Cap Growth A
JOHAX29.76-0.01
-0.03%
JOHCM International Select Investor
PRHSX94.44-0.31
-0.33%
T. Rowe Price Health Sciences
THMEX16.85-0.07
-0.41%
CCT Thematic Equity Institutional
BRSYX16.90-0.09
-0.53%
MFS Blended Research Small Cap Eq R6